RecruitingPhase 1 / Phase 2NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Long Island City, NY · Syracuse, NY · +15 more sites
Prostate Cancer clinical trials in Syracuse, NY
3 recruiting prostate cancer studies with a site in Syracuse, NY.
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
New York, NY · Syracuse, NY · The Bronx, NY · +32 more sites
RecruitingPhase 2NCT06134232
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
North Hills, NY · Syracuse, NY · +29 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.